GO
Loading...

Enter multiple symbols separated by commas

U.S. Regulators OK Generic Version Of Ambien Sleeping Pill

Mylan Laboratories said U.S. regulators approved its generic version of Sanofi-Aventis' sleeping pill, Ambien, in the 5 mg and 10 mg strengths.

In a statement, the generic drug maker said the product is being shipped immediately.

Ambien had sales of about $2.2 billion in the U.S. for the same strengths for the 12-month period ending Dec. 31, 2006, according to IMS Health.

Sanofi-Aventis lost patent protection for Ambien on April 21. Ambien dominates the U.S. sleeping pill market, which is growing at about 10% a year.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

U.S. Video

  • Getting money to Greece

    Greek citizen Nektaria Pateraki explains the struggle of living in Greece and being limited to 60 euros a day as her cousin in America sends money through an online website.

  • CNBC update: Tour de France crash

    Iran's state news agency says serious differences remain after a ministerial meeting in Vienna, and the Tour De France bicycle race came to a grinding halt after a massive pile up caused 2 dozens riders to topple over, reports CNBC's Sue Herera.

  • US businesses wait for Greek imports

    U.S. business owners are worrying about potential shortages of everything from Greek olive oil to Greek sea sponges on American store shelves.